Table 5.
New significant signals in type 2 diabetes loci in the Black Women’s Health Study
Locus | Index SNP | Best SNP1 |
r2 with index EUR/AFR |
||||||
---|---|---|---|---|---|---|---|---|---|
SNP, alleles2 | EAF3 | OR4 (95% CI), P-value |
SNP, alleles2 | EAF3 | OR4 (95% CI), P-value |
||||
BWHS | EUR | BWHS | EUR | ||||||
PROX1 1q32 |
rs2075423, G/T | 0.63 | 0.63 | 1.03 (0.95–1.12), 0.49 | rs120914475, A/G | 0.97 | 0.98 | 1.55 (1.24–1.95), 1.1×10−4 | <0.01/<0.01 |
ANKRD55 5q11 |
rs459193, G/A | 0.58 | 0.71 | 1.09 (1.01–1.18), 0.037 | rs73127858, T/C | 0.11 | 0.001 | 1.29 (1.14–1.47), 7.1×10−5 | 0.0/0.0 |
GLIS3 9p24 |
rs7041847, A/G | 0.87 | 0.53 | 1.10 (0.98–1.24), 0.11 | rs1145607815, C/A | 0.02 | 0.0 | 1.80 (1.35–2.39), 6.6×10−5 | 0.0/0.0 |
TCF7L2 10q25 |
rs7903146, T/C | 0.30 | 0.32 | 1.20 (1.10–1.31), 2.4×10−5 | rs114770437, G/A | 0.93 | 1.0 | 1.37 (1.18–1.61), 6.4×10−5 | 0.0/0.03 |
HMGA2 12q14 |
rs1531343, C/G | 0.37 | 0.13 | 0.99 (0.91–1.07), 0.74 | rs2583943, A/G | 0.81 | 0.16 | 1.25 (1.12–1.39), 5.7×10−5 | 0.67/0.03 |
rs1163330535, A/C | 0.05 | 0.001 | 1.44 (1.19–1.74), 1.8×10−4 | <0.01/<0.01 |
Most significant SNP with locus-wide significant fine-mapping results
Effect allele/reference allele
Effect allele frequency in the current study (BWHS), and European (EUR) ancestry populations from 1000 Genomes Project
Odds ratios adjusted for % African ancestry, age, and geographic region of residence
Imputed SNPs: rs12091447 info = 0.93; rs114560781 info = 0.95; rs116333053 info = 0.94